Atomo Diagnostics reports 41% revenue growth, improved EBITDA
Atomo Diagnostics said revenue grew 41% and EBITDA improved, citing new products and leadership.
Story updates
11:39:11 PM UTC
SquawkNews
Atomo Diagnostics: Revenue up 41% and net loss down 29% year-over-year, with strong HIV and POC tech sales growth
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.